Stokes Family Office’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Buy |
+4,517
| New | +$240K | 0.03% | 213 |
|
|
2025
Q1 | – | Sell |
-4,413
| Closed | -$248K | – | 239 |
|
|
2024
Q4 | $248K | Hold |
4,413
| – | – | 0.03% | 212 |
|
|
2024
Q3 | $301K | Buy |
+4,413
| New | +$301K | 0.03% | 191 |
|
|
2024
Q2 | – | Sell |
-4,413
| Closed | -$305K | – | 225 |
|
|
2024
Q1 | $305K | Hold |
4,413
| – | – | 0.04% | 185 |
|
|
2023
Q4 | $326K | Sell |
4,413
-1,709
| -28% | -$126K | 0.04% | 168 |
|
|
2023
Q3 | $418K | Hold |
6,122
| – | – | 0.05% | 203 |
|
|
2023
Q2 | $575K | Hold |
6,122
| – | – | 0.07% | 160 |
|
|
2023
Q1 | $415K | Hold |
6,122
| – | – | 0.05% | 189 |
|
|
2022
Q4 | $303K | Buy |
+6,122
| New | +$303K | 0.04% | 215 |
|
|
2022
Q3 | – | Sell |
-6,538
| Closed | -$258K | – | 279 |
|
|
2022
Q2 | $258K | Buy |
6,538
+2,100
| +47% | +$82.9K | 0.04% | 227 |
|
|
2022
Q1 | $310K | Hold |
4,438
| – | – | 0.04% | 204 |
|
|
2021
Q4 | $345K | Hold |
4,438
| – | – | 0.04% | 176 |
|
|
2021
Q3 | $424K | Buy |
4,438
+72
| +2% | +$6.88K | 0.06% | 160 |
|
|
2021
Q2 | $543K | Hold |
4,366
| – | – | 0.08% | 135 |
|
|
2021
Q1 | $575K | Sell |
4,366
-2
| -0% | -$263 | 0.09% | 123 |
|
|
2020
Q4 | $579K | Buy |
4,368
+15
| +0.3% | +$1.99K | 0.11% | 108 |
|
|
2020
Q3 | $444K | Hold |
4,353
| – | – | 0.1% | 108 |
|
|
2020
Q2 | $378K | Buy |
4,353
+53
| +1% | +$4.6K | 0.1% | 108 |
|
|
2020
Q1 | $249K | Sell |
4,300
-12
| -0.3% | -$695 | 0.07% | 108 |
|
|
2019
Q4 | $399K | Buy |
+4,312
| New | +$399K | 0.09% | 104 |
|